ACTICOR BIOTECH

Innovative drug for the treatment of acute thrombotic diseases

Acticor Biotech is a clinical stage biotechnology company, founded in 2013 as a spin-off of INSERM, developing an innovative drug for the treatment of acute thrombotic diseases, including the acute phase of ischemic stroke.

Retrouvez nos autres références Biotechnology & Nutrition